{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T01:16:44Z","timestamp":1648603004693},"reference-count":10,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2014]]},"DOI":"10.2169\/internalmedicine.53.2553","type":"journal-article","created":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T23:28:43Z","timestamp":1413329323000},"page":"2291-2296","source":"Crossref","is-referenced-by-count":2,"title":["Experience with Seven Japanese Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis Treated with Remission-induction Therapy with Intravenous Cyclophosphamide according to the CYCLOPS Protocol"],"prefix":"10.2169","volume":"53","author":[{"given":"Hiroshi","family":"Oiwa","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Hiroshima City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Yamasaki","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Endo","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaki","family":"Nojima","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Kumagai","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Sugiyama","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. de Groot K, Harper L, Jayne DR, et al. Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann Intern Med 150: 670-680, 2009."},{"key":"2","unstructured":"2. The Ministry of Health, Labor and Welfare. Treatment of rapidly progressive glomerulonephritis. In: Clinical Practice Guideline for ANCA-associated Vasculitis. Shinano Publishing Press, Tokyo, 2011: 46-48. Available from: http:\/\/minds4.jcqhc.or.jp\/minds\/ANCA\/anca.pdf (in Japanese)."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Guillevin L, Lhote F, Gayraud M, et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 75: 17-28, 1996.","DOI":"10.1097\/00005792-199601000-00003"},{"key":"4","unstructured":"4. Luqmani RA, Bacon PA, Moots RJ, et al. Birmingham Vasculitis Activity Score (BVAS) Dim systemic necrotizing vasculitis. QJM 87: 671-678, 1994."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. McAllister WA, Thompson PJ, Al-Habet SM, Rogers HJ. Rifampicin reduces effectiveness and bioavailability of prednisolone. Br Med J (Clin Res Ed) 286: 923-925, 1983.","DOI":"10.1136\/bmj.286.6369.923"},{"key":"6","unstructured":"6. Oshikawa H, Minota M, Nakano H, et al. Efficacy and safety of induction therapy with pulse cyclophosphamide for ANCA-associated vasculitis [abstract]. The 57th Annual General Assembly and Scientific Meeting of the Japanese College of Rheumatology. 2013: Workshop 46-5."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Lapraik C, Watts R, Bacon P, et al. BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis. Rheumatology (Oxford) 46: 1615-1616, 2007.","DOI":"10.1093\/rheumatology\/kem146a"},{"key":"8","unstructured":"8. Study group on refractory vasculitis. In: Medical Mannual on Refractory Vasculitis. the Ministry of Health, Labor and Welfare, 2002: 90-91 (in Japanese)."},{"key":"9","unstructured":"9. Harper L, Morgan MD, Walsh M, et al. Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up. Ann Rheum Dis 71: 955-960, 2012."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Fujimoto S, Watts RA, Kobayashi S, et al. Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K. Rheumatology 50: 1916-1920, 2011.","DOI":"10.1093\/rheumatology\/ker205"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/20\/53_53.2553\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:52:30Z","timestamp":1621446750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/20\/53_53.2553\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":10,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.53.2553","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}